Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVA237 in Moderate to Severe COPD
NCT01119950Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Novartis. Started Apr 2010; status: completed.
02
Drugs
glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01119950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119950.